Shares of precision measurement company Mettler-Toledo (NYSE:MTD)
fell 5.1% in the afternoon session after investors focused on declining profitability and the future impact of new tariffs, even though the company's second-quarter results beat analyst expectations. While Mettler-Toledo posted higher sales and adjusted earnings that surpassed forecasts, its reported net income and earnings per share declined from the previous year. Investors appeared concerned by shrinking profit margins, as the company's gross margin fell. The company also pointed to newly announced tariffs on goods imported from Switzerland, which created uncertainty around future profits. These company-specific headwinds occurred amid a broader market downturn fueled by a weak jobs report and widespread trade fears.
Curious about the market action on Friday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.
Precision measurement company Mettler-Toledo (NYSE:MTD) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 3.9% year on year to $983.2 million. The company expects next quarter’s revenue to be around $987.9 million, close to analysts’ estimates. Its non-GAAP profit of $10.09 per share was 5.1% above analysts’ consensus estimates.
Even if a company is profitable, it doesn’t always mean it’s a great investment.
Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
METTLER-TOLEDO (NYSE:MTD) is a high-quality stock with strong ROIC, profit margins, and cash flow conversion, making it a candidate for long-term investors.
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance.
Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations.
However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.
Looking back on research tools & consumables stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Mettler-Toledo (NYSE:MTD) and its peers.
When Wall Street turns bearish on a stock, it’s worth paying attention.
These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.
Stay updated with the movements of the S&P500 index in the middle of the day on Tuesday. Discover which stocks are leading as top gainers and losers in today's session.
Precision measurement company Mettler-Toledo (NYSE:MTD) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 4.6% year on year to $883.7 million. Its non-GAAP profit of $8.19 per share was 3.9% above analysts’ consensus estimates.
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Wednesday as we examine the latest happenings in today's session.
A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides agreed to pause some tariffs for 90 days, signaling a potential turning point in ongoing tensions. This rollback cuts U.S. tariffs on Chinese goods to 30% and Chinese tariffs on U.S. imports to 10%, giving companies breathing room to reset inventories and supply chains.
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns -
over the past six months, healthcare stocks have collectively shed 13.3%. This performance was worse than the S&P 500’s 5.8% fall.
A company that generates cash isn’t automatically a winner.
Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
U.S. stocks advanced across the board by midday Friday, with the S&P 500 eyeing its ninth consecutive day of gains—poised for the longest winning streak since May 2024.
Precision measurement company Mettler-Toledo (NYSE:MTD) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales fell by 4.6% year on year to $883.7 million. Its non-GAAP profit of $8.19 per share was 3.9% above analysts’ consensus estimates.
Wall Street pushed higher in midday trading, with the S&P 500 on track for its eighth consecutive gain — its longest winning streak since November 2023. The index rose about 1% to 5,560, fully recovering the losses sustained after former President Donald Trump announced trade tariffs on April 2.
